Intra-arterial chemotherapy in retinoblastoma - A paradigm change.

Détails

ID Serval
serval:BIB_ED35080F98FE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
Périodique
Indian journal of ophthalmology
Auteur(s)
Manjandavida F.P., Stathopoulos C., Zhang J., Honavar S.G., Shields C.L.
ISSN
1998-3689 (Electronic)
ISSN-L
0301-4738
Statut éditorial
Publié
Date de publication
06/2019
Peer-reviewed
Oui
Volume
67
Numéro
6
Pages
740-754
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide. Following the introduction of the technique in 1998, IAC has evolved over the past decades to be safer and more effective. Accumulated evidence shows that IAC is more effective in providing eye salvage in group D and E retinoblastoma as compared to conventional systemic intravenous chemotherapy (IVC). In contrast to IVC, IAC has the added benefits of reduced overall treatment duration and minimal systemic toxicity. This review provides a comprehensive update on the history, technique, indications, contraindications, and outcome of IAC. We have also identified the strengths, weaknesses, opportunities and threats (SWOT analysis) of the technique in this review.
Mots-clé
Antineoplastic Agents/administration & dosage, Humans, Injections, Intra-Arterial, Ophthalmic Artery, Retinal Neoplasms/drug therapy, Retinoblastoma/drug therapy, Retinoblastoma, chemosurgery, intra-arterial chemotherapy, selective ophthalmic artery chemotherapy, superselective ophthalmic artery chemotherapy
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/06/2019 16:57
Dernière modification de la notice
12/09/2019 5:10
Données d'usage